Screening of the key response component groups and mechanism verification of Huangqi-Guizhi-Wuwu-Decoction in treating rheumatoid arthritis based on a novel computational pharmacological model

Screening of the key response component groups and mechanism verification of Huangqi-Guizhi-Wuwu-Decoction in treating rheumatoid arthritis based on a novel computational pharmacological model

Abstract Background Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by the destruction of synovial tissue and articular cartilage. Huangqi-Guizhi-Wuwu-Decoction (HGWD), a formula of Traditional Chinese Medicine (TCM), has shown promising clinical efficacy in the treatment of...

Full description

Bibliographic Details
Main Authors: Qinwen Liu, Qian Luo, Qiling Fan, Yi Li, Aiping Lu, Daogang Guan
Format: Article
Language:English
Published: BMC 2024-01-01
Series:BMC Complementary Medicine and Therapies
Subjects:
Rheumatoid arthritis
Huangqi-Guizhi-Wuwu-Decoction
Network pharmacology
Key response components group
Online Access:https://doi.org/10.1186/s12906-023-04315-y

Internet

https://doi.org/10.1186/s12906-023-04315-y

Similar Items